C

Medexus Pharmaceuticals Inc. MDP.TO

TSX
Recommendation
Dividend Power Score
Day's Range
$4.92$5.06
Latest Close
Volume
--
Avg Vol (90D)
Market Cap
Dividend & Yield
--
P/E (TTM)
--
EPS (TTM)
My Lists My Alerts

09/30/2026 06/30/2026 03/31/2026 12/31/2025 09/30/2025
Net Income 358.10% 5.43% -383.73% -89.09% -386.36%
Total Depreciation and Amortization -0.49% -0.54% 0.82% 38.04% 54.06%
Total Amortization of Deferred Charges -- -- -- -- --
Total Other Non-Cash Items -81.51% 169.77% 1,516.81% -49.44% -58.21%
Change in Net Operating Assets 753.45% -919.83% 29.89% 197.30% -118.76%
Cash from Operations 61.94% -118.55% 66.39% 16.71% -51.32%
Capital Expenditure -328.57% 82.40% 94.34% 68.85% 81.08%
Sale of Property, Plant, and Equipment -- -- -- -- --
Cash Acquisitions 11.04% -20.05% 76.22% -8.53% -270.34%
Divestitures -- -- -- -- --
Other Investing Activities -- 20.00% -- -11,527.91% --
Cash from Investing 9.61% -5.30% -286.86% -1,032.78% 44.50%
Total Debt Issued -- -- -- -- --
Total Debt Repaid 95.16% 96.28% 6.76% -541.35% 72.19%
Issuance of Common Stock -- -- -97.44% -- --
Repurchase of Common Stock -- -- -- -- --
Issuance of Preferred Stock -- -- -- -- --
Repurchase of Preferred Stock -- -- -- -- --
Total Dividends Paid -- -- -- -- --
Other Financing Activities 33.94% 43.30% 51.22% 53.18% 64.72%
Cash from Financing 44.72% 112.43% -127.52% 170.43% 70.47%
Foreign Exchange rate Adjustments 55.88% -116.67% -155.56% 115.56% -156.67%
Miscellaneous Cash Flow Adjustments -- -- -- -- --
Net Change in Cash 6,040.82% 91.95% -154.42% 281.06% 103.31%